IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.IDEXX Laboratories Inc. (IDXX) shares fell 1.35% to $545.00 on Wednesday, underperforming competitors like Johnson & Johnson and Medtronic during a broadly weak market session. This marks the fourth consecutive day of losses for IDEXX, which is now trading 29.22% below its 52-week high. Trading volume remained significantly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. (IDXX) slid 1.35% to $545.00 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.14% to 7,498.96 and Dow Jones Industrial Average falling 0.01% to 52,218.58.
This was the stock's fourth consecutive day of losses.
IDEXX Laboratories Inc. closed 29.22% below its 52-week high of $769.98, which the company achieved on November 26th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 2.00% to $255.63, Medtronic PLC (MDT) fell 0.56% to $81.89, and Boston Scientific Corp. (BSX) fell 0.51% to $42.97.
Trading volume (478,672) remained 185,402 below its 50-day average volume of 664,074.
Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-22-26 1651ET